Learn more about this record-breaking donation

In an astounding display of philanthropy that has sent ripples through the healthcare and charitable communities, two of the nation's most prolific billionaires, David Geffen and Ken Griffin, have jointly committed to a record-breaking donation of $400 million to the Memorial Sloan Kettering Cancer Center. This historic contribution, which marks one of the largest gifts ever made to a medical institution, stands as a testament to the power of impactful giving and a beacon of hope in the relentless fight against cancer. As benefactors with deep pockets cast their lot with the pioneers on the frontier of medical research, it's essential to delve into the significance of their decision and its potential ramifications. Join us as we explore the monumental implications of Geffen and Griffin's philanthropic partnership, undoubtedly catalyzing advancements in cancer care, research, and treatment at one of the world's most prestigious centers dedicated to conquering this formidable disease.

Billionaires Geffen and Griffin Donate Record-Breaking $400 Million to Memorial Sloan Kettering Cancer Center

**New York, NY** - In a historic act of philanthropy, billionaires David Geffen and Kenneth Griffin have pledged a combined $400 million to the Memorial Sloan Kettering Cancer Center (MSK). This marks the largest single donation in the hospital's history and one of the largest ever made to a medical institution.

The news was first announced on Good Morning America (GMA), where co-hosts Robin Roberts and Lara Spencer became emotional while discussing the donation's potential impact. Roberts, a cancer survivor herself, expressed her gratitude to Geffen and Griffin for their generosity. "This gift will save countless lives and give hope to millions of people facing cancer," she stated.

**A Monumental Step in Cancer Research**

The $400 million donation will be used to support various initiatives at MSK, including:

• * **Cancer research:** The funds will accelerate the development of new cancer treatments and therapies.

• * **Patient care:** This will enable MSK to expand access to its world-class care and improve patient outcomes.

• * **Education and training:** The donation will support the training of the next generation of cancer specialists.

David Geffen, a renowned entertainment mogul, has a long history of supporting cancer research. He previously donated $100 million to UCLA's cancer center in 2015. Kenneth Griffin, the CEO of Citadel LLC, has also been a vocal advocate for cancer research and has made significant contributions to various cancer charities.

**A Beacon of Hope**

The historic donation by Geffen and Griffin has been met with widespread praise from the medical community. Dr. Craig Thompson, the president and CEO of MSK, called the gift "a game-changer" and said it will "propel our cancer research and treatment efforts to new heights."

This record-breaking donation marks a significant step forward in the fight against cancer. With the support of philanthropists like Geffen and Griffin, MSK is well-positioned to continue its groundbreaking work in cancer research and treatment, offering hope to millions of patients around the world.